The light solution for Barrett's oesophagus: Photodiagnosis and photodynamic therapy for columnar-lined oesophagus

Photodiagnosis and Photodynamic Therapy

Volumn 1, Issue 1, 2004, Pages 75-84

  Barr, H ^a   Kendall, C ^a   Stone, N ^a  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Barrett's oesophagus; Dysplastic; Optical diagnosis

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DYSPLASIA; ENDOSCOPY; HUMAN; IMAGING SYSTEM; INFLAMMATION; LIGHT; LIGHT SCATTERING; MOLECULAR BIOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PHOTODIAGNOSIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAMAN SPECTROMETRY; SPECTROFLUOROMETRY; STATISTICAL SIGNIFICANCE;

EID: 14644439861     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1572-1000(04)00011-0     Document Type: Article

References (72)

1. Jankowski J, Harrison R.F, Perry I, Balkwill F, Tselepis C. Seminar: Barrett's metaplasia. Lancet. 356:2000;2079-2085
2. Dulai G.S. Surveying the case for surveillance. Gastroenterology. 122:2002;820-825
3. Barr H. Endoscopic surveillance of patients with Barrett's oesophagus. Gut. 51:2002;313-314
4. Playford RJ. Endoscopic surveillance of patients with Barrett's oesophagus. Gut 2002:314-5.
5. Corley D.A, Levin T.R, Weiss N.S, Buffer P.A. Surveillance and survival in Barrett's adenocarcinoma: a population-based study. Gastroenterology. 122:2002;633-640
6. Tremble K.C, Pryde A, Heading R.C. Lowered oesophageal sensory thresholds in patients with symptomatic but not excessive gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GERD. Gut. 37:1995;7-12
7. Gerson L.B, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in assymptomatic individuals. Gastroenterology. 123:2002;461-467
8. Attwood S.E.A, Morris C.D. Who defines Barrett's oesophagus: endoscopist or pathologist? Eur. J. Gastroenterol. Hepatol. 19:2001;97-99
9. Spechler S.J. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology. 117:1999;218-228
10. Kim S.L, Waring J.P, Spechler S.J, et al. Diagnostic Inconsistencies in Barrett's esophagus. Gastroenterology. 107:1994;945-949
11. Levine D.S, Haggitt R.C, Blount P.L, Rabinovitch P.S, Rusch V.W, Reid B.J. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology. 105:1993;40-50
12. Cameron A.J, Carpenter H.A. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol. 92:1997;586-591
13. Riddell R.H, Goldman H, Ransohoff D, et al. Dysplasia in inflammatory bowel disease. Standardised classification with provisional clinical application. Hum Pathol. 14:1983;931-966
14. Haggitt R.C. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol. 25:1994;982-993
15. Montgomery E, Bronner M.P, Goldblum J.R, et al. Reproducibility of the diagnosis of dysplasia in Barrett's oesophagus: a reaffirmation. Hum Path. 32:2001;268-378
16. Reid B.J, Blount P.L, Rubin C.E, Levine D.S, Haggitt R.C, Rabinovitch P.S. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology. 102:1992;1212-1219
17. Whittles CE, Biddlestone LR, Burton A, et al. Apoptotic and proliferative activity in the neoplastic progression in Barrett's oesophagus: a comparative study. J Pathol 187:535-40.
18. Bailey T, Biddlestone L, Shepherd N, Barr H, Warner P, Jankoski J. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia- adenocarcinoma sequence. Correlation with disease progression and dedifferentiation. Am J Pathol. 152:1998;1-10
19. Sokolov K, Aaron J, Hsu B, et al. Optical systems for in-vivo molecular imaging of cancer. TCRT. 2:2003;491-504
20. Panjepour M, Overholt B.F, Vo-Dinh T, Haggitt R.C, Edwards D.H, Buckley F.P. Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus. Gastroenterlogy. 111:1996;93-111
21. Egger K, Werner M, Meining A, et al. Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut. 52:2003;18-23
22. Sharma P, Weston A.P, Topalovski M, et al. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut. 52:2003;24-27
23. Ortner M.-A, Ebert B, Hein E, et al. Time gated fluorescence spectroscopy in Barrett's oesophagus. Gut. 52:2003;28-33
24. Song J.M, Jagannathan D.L, et al. Development of a fluorescence detection system using optical parametric oscillator (OPO) laser excitation for excitation for in vivo diagnosis. TCRT. 2:2003;515-523
25. Tunnell J.W, Desjardins A.E, Galindo L, et al. Instrumentation for multi-modal spectroscopic diagnosis of epithelial dyspolasia. TCRT. 2:2003;505-514
26. Pavlova I, Sokolov K, Drezek R, Malpica A, Follen M, Richards-Kortum R. Microanatomocal and biochemical origins of normal and precancerous cervical autofluorescence using laser-scanning fluorescence confocal microscopy. Photochem Photobiol. 77:2003;550-555
27. Tearney G.J, Brezinski M.E, Bouma B.E. In vivo endoscopic optical biopsy with optical coherence tomography. Science. 276:1997;2037-2039
28. Tearney G.J, Brezinski M.E, Southern J.F, Bouma B.E, Boppart S.A, Fujimoto J.G. Optical biopsy in human gastrointestinal tissue using optical coherence tomography. Am J Gastrol. 92:1997;1800-1804
29. Barton J.K, Gossage K.W, Xu W, et al. Investigating Sun-damaged skin and actinic keratosis with optical coherence tomography: a pilot study. TCRT. 2:2003;525-535
30. Mourant J.R, Bigio I.J, Boyer J.D, et al. Elastic scattering spectroscopy as a diagnostic tool for differentiating pathologies in the gastrointestinal tract. J Biomed Opt. 1:1996;192-199
31. Wallace M.B, Perelman L.T, Backman V, et al. Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattering spectroscopy. Gastroenterology. 119:2000;677-682
32. Dudovich N, Oron D, Silberberg Y. Single-pulse coherently controlled nonlinear Raman spectroscopy and microscopy. Nature. 418:2002;512-514
33. Shim M.G, Wilson B.C, Marple E, Wach M. Study of fiber-optic probes for in vivo medical Raman spectroscopy. Appl. Spectrosc. 53:1999;619-627
34. Stone N, Kendall C, Shepherd N, Crow P, Barr H. Near-infrared spectroscopy for classification of epithelial pre-cancers and cancers. J Raman Spectrosc. 33:2002;564-573
35. Kendall C, Stone N, Shepherd N, et al. Raman spectroscopy a potential tool for the objective identification and classification of neoplasia in Barrett's oesophagus. J Pathol. 200:2003;602-609
36. Shepherd N.A. Barrett's oesophagus and proton pump inhibitors: a pathological perspective. Gut. 46:2000;147-149
37. Zaninotto A.R, Ruol A, Costantini M, Merigliano S, Ancona E. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. BJS. 97:2000;1102-1105
38. Altorki N.K, Sunagawa M, Little A.G, Skinner D.B. High-grade dysplasia in the columnar-lined esophagus. Am J Surg. 161:1991;97-99
39. Pera M, Trastek V.F, Carpenter H.A, Allen M.S, Deschamps C, Pairolero P.C. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg. 54:1992;199-204
40. Rice T.W, Falk G.W, Achkar E, Petras R.E. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Surg. 174:1997;1832-1836
41. Steitz J.M Jr., Andrews C.W Jr., Ellis F.H Jr. Endoscopic surveillance of Barrett's oesophagus. Does it help? J Thorac Cardiovasc Surg. 105:1993;383-388
42. Levine D.S, Haggitt R.C, Blount P.L, Rabinovitch P.S, Rusch V.W, Reid B.J. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology. 105:1993;40-50
43. Peters J.H, Clark G.W, Ireland A.P, Chandrasoma P, Smyrk T.C, DeMeester D.R. Outcome of adenocarcinoma in Barrett's esophagus inendoscopically surveyed and non-surveyed patients. J Thorac Cardiovasc Surg. 108:1994;813-821
44. Edwards M.J, Gable D.R, Lentsch A.B, Richardson J.D. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg. 223:1996;585-589
45. Collard J.M, Romagnoli R, Hermans B.P, Malaise J. Radical esophageal resection for adenocarcinoma arising in Barrett's esophagus. Am J Surg. 174:1997;307-311
46. Heitmeller R.F, Redmond M, Hamilton S.R. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg. 224:1996;66-71
47. Ferguson M.K, Naunheim K.S. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg. 114:1997;824-829
48. Cameron A.J, Carpenter H.A. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol. 92:1997;586-591
49. Palley S.L, Sampliner R.E, Garewal H.S. High-grade dysplasia in Barrett's oesophagus. J Clin Gastroenterol. 11:1989;369-372
50. Bachmann M.O, Alderson D, Edwards D, et al. Cohort study in South and West England of the influence of specialization on management and outcome of patients with oesophageal and gastric cancers. BJS. 89:2002;914-922
51. Bollschweiler E, Schroder W, Holscher A.H, Siewert J.R. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. BJS. 87:2000;1106-1110
52. Barr H, Fitzgerald R.C. Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer. Gut. 52:2003;14-17
53. Ackroyd R, Brown N.J, Stephenson T.J, Stoddard C.J, Reed M.W. Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed? J Clin Pathol. 52:1999;509-512
54. Bamford K, James J, Barr H, Tatam R. Electromagnetic simulation of laser-induced fluorescence in bronchial tissue and predicted optical scattering behaviour. Opt. Imaging Tech. Biomonit. IV. 3567:1998;18-28
55. Barr H, Shepherd N.A, Dix A, Roberts D.J.H, Tan W.C, Krasner N. Eradication of high grade dysplasia in columnar-lined (Barrett's) oesophagus using photodynamic therapy with endogenously generated protoporphyrin IX. Lancet. 348:1996;584-585
56. Loh C.S, Bedwell J, MacRobert A.J, Krasner N, Phillips D, Bown S.G. Photodynamic therapy of the normal rat stomach-a comparative study between disulfonated aluminium phthalocyanine and 5-aminolevulinic acid. Br J Cancer. 66:1992;452-462
57. Van den Boogert J, Van Hillegersberg R, Van Staveren H.J, De Bruin R.W.F, Siersema P.D, Tilanus H.W. Timing of illumination is essential for effective and safe photodynamic therapy: a study in the normal rat oesophagus. Br J Cancer. 79:1999;825-830
58. Tan WC, Fulljames C, Stone N, et al. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia. J Photochem Photobiol B Biol 53:75-80.
59. Gossner L, Stolte M, Stroke R, et al. Photodynamic therapy of high-grade dysplasia and early stage carcinomas by means of 5-aminolaevulinic acid. Gastroenterology. 114:1998;447-455
60. Ackroyd R, Brown N.J, Davis M.F, et al. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomized, placebo controlled trial. Gut. 47:2000;613-617
61. Ortner M, Zumbusch K, Liebetruth J, et al. Photodynamic therapy in Barrett's esophagus after local administration of 5-aminolaevulinic acid. Gastroenterology. 112:1997;A633
62. Barr H. Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy. Gastrointest Endo Clin N Am. 10:2000;421-437
63. Moghissi K, Dixon K. Photodynamic therapy (PDT) in esophageal cancer: a surgical view based on 14 years experience. TCRT. 2:2003;319-326
64. Sibille A, Lambert R, Souquet J.C, Sabben G, Decos F. Long term survival after photodynamic therapy for oesophageal cancer. Gastroenterology. 1008:1995;3378-3384
65. Stone N. Standardizing dosimetry in esophageal PDT: an arquement for use of centering devices and removal of misleading units. TCRT. 2:2003;333-338
66. Overholt B.F, Panjepour M, Haydek J.M. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc. 49:1999;1-7
67. Overholt B.F, Panjepour M, Halberg D.L. Photodynamic therapy for Barrett's oesophagus with dysplasia and/or early carcinoma: long term results. Gastrointest Endosc. 58:2003;183-188
68. International multicenter partially blinded randomised study of the efficacy of photodynamic therapy (PDT) using Porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in Barrett's esophagus (BE): results of 24 month follow-up. Overholt BF, Lightdale CJ, Wang K, et al. Gastroenterology 2003;124:A20, 151.
69. Wong K, Song L.-M, Wang K.K. Optical detection and eradication of dysplastic Barrett's esophagus. TCRT. 2:2003;289-302
70. Barr H, Kendall C, Stone N. Photodynamic therapy for oesophageal cancer. A realistic and useful option. TCRT. 2:2003;65-75
71. Clarke L.P, Baker H. Kelloff potential of optical imaging for early cancer detection, screening, diagnosis and image guided treatment. TCRT. 2:2003;487-490
72. Barr H. Fiat lux light detection and destruction of cancer with photodynamic therapy. TCRT. 2:2003;281-282